パルボウイルスB19感染による純粋赤血球無形成症とアテゾリズマブ:症例報告と文献レビュー
PubMedで要約を見る
まとめ
この要約は機械生成です。アテゾリズマブのような免疫チェックポイント阻害剤は重度の貧血を引き起こす可能性があります. この症例は,アテゾリズマブとパルボウイルスB19感染と関連した 純粋な赤血球無形成症の患者で,ステロイドで治療に成功しました.
科学分野
- 腫瘍学
- 免疫学
- 血液学
背景
- 免疫チェックポイント阻害剤 (ICI) は,がん治療において有意な効果をもたらしますが,免疫関連の有害事象 (irAEs) と関連しています.
- ICI誘発のIRA,特に血液学的合併症の正確なメカニズムについては,さらなる解明が必要である.
- アテゾリズマブ/ ベバシズマブによる肝細胞癌 (HCC) 治療は,様々な有害事象を引き起こす可能性があります.
研究 の 目的
- アテゾリズマブ/ ベバシズマブで治療された高度なHCC患者の重度の貧血を報告する.
- アテゾリズマブとパルボウイルスB19感染と純粋赤血球無形成症 (PRCA) の間の潜在的な関連を調査する.
- この珍しい有害事象の管理と結果について説明します.
主な方法
- 進行したHCCの69歳の患者の症例報告
- 骨髄アスピレーションの分析,赤色線評価とパルボウイルスB19 PCRを含む.
- 治療には,輸血,静脈内免疫グロブリン,一時的なICI中断,およびその後のコルチコステロイド療法が含まれていた.
主要な成果
- 患者は重度の貧血を発症し,当初はパルボウイルスB19誘発のPRCAに起因していた.
- アテゾリズマブ/ ベバシズマブの再投与で貧血が再発し,ICIに関連する病因を示唆した.
- プレドニゾンの治療は,ヘモグロビン濃度の有意な改善と貧血の解消につながった.
結論
- アテゾリズマブは,パルボウイルスB19のようなウイルス感染症によって悪化する可能性があるPRCAを含む血液学的有害事象と関連付けられる.
- コルチコステロイド治療は,ICIに関連するPRCAの管理に有効である.
- このケースは,治療中に原因不明の貧血を発症する患者のICI毒性を考慮することの重要性を強調しています.
関連する概念動画
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...

